COVID-19 Vaccine

The following Marylanders are currently eligible for a COVID-19 booster:

Marylanders 5+ who received their primary series or booster dose of any authorized or approved monovalent COVID-19 vaccine at least 2 months ago
Marylanders 18+ who received the Johnson & Johnson COVID-19 vaccine at least 2 months ago

NOTE: Marylanders 5-6 are eligible for the Pfizer bivalent booster only. Marylanders 6+ may choose which bivalent vaccine they want for a booster, even if it is different from the primary vaccine series received.

All Marylanders 6 months and older are eligible for all COVID-19 primary vaccine series. Vaccinations are available through pediatricians and other physicians, hospitals, local health departments, and pharmacies.

Keep Reading Resources FAQs

Appointment info Booster Eligibility

Find a vaccination clinic near you

The Food and Drug Administration has granted full approval for the Pfizer vaccine for individuals ages 12 and older and full approval for the Moderna vaccine for ages 18 and older. Emergency use authorizations for the Pfizer and Moderna vaccines are in effect for individuals 6 months through 11 for Pfizer, and 6 months through 17 for Moderna. Emergency use authorizations for the Pfizer and Moderna bivalent booster vaccines are in effect for Marylanders 5+ for Pfizer, and Marylanders 6+ for Moderna.

Emergency use authorization for the Novavax vaccine as a primary vaccination series and booster is also in effect for individuals 18 and older. All Marylanders 6 months and older are eligible for initial COVID-19 vaccination. Vaccinations are available through pediatricians and other physicians, hospitals, local health departments and pharmacies.

Schedule an appointment

Why should you get the vaccine?

ProtectsLearn how it protects you from COVID-19-related serious illness and death.

Woman suffering in bed with a fever and flu like symptoms

PreventsLearn how it prevents you from experiencing dangerous long-haul COVID-19 symptoms.

DefendsLearn how it defends against new, more contagious, and even deadlier variants of COVID-19.

What are the vaccines?

CDC has updated its recommendations for COVID-19 vaccines with a preference for people to receive an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna). Learn more.

Vaccines	Status	Dosing	Potential Side Effects
Pfizer	Original, monovalent vaccine has been approved for use as a primary series for ages 12+; authorized for emergency use for ages 6 months to 11 years as a primary series; bivalent booster dose authorized for emergency use for ages 5+.	Primary series: Two doses, delivered three weeks apart Bivalent booster: single dose, 2 months after completing primary vaccine series or last monovalent booster received	Injection-site pain, fatigue, headaches, chills
Moderna	Original, monovalent vaccine has been approved for use as a primary series for ages 18+; authorized for emergency use for ages 6 months to 17 years as a primary series; bivalent booster dose authorized for emergency use for ages 6+.	Primary series: Two doses, delivered four weeks apart Bivalent booster: single dose, 2 months after completing primary vaccine series or last monovalent booster received.	Injection-site pain, fatigue, muscle aches, joint pain, headaches, chills
Johnson & Johnson	Vaccine has been authorized for emergency use for ages 18+	One dose primary series	Injection site pain, fatigue, headache, muscle pain, joint pain
Novavax	Vaccine has been authorized for emergency use as a primary series and booster for ages 18+	Primary Series: Two doses, three weeks apart Monovalent booster: Single dose, at least six months after primary series from any authorized vaccine	Injection site pain, fatigue, headache, muscle pain, joint pain
AstraZeneca	Vaccine trials are ongoing	Two dose primary series, delivered four weeks apart	Fever, muscle aches, headaches, injection site pain

Prevention from Covid (Pre-exposure treatment)

The best protection against severe illness from COVID is to be up-to-date on all recommended COVID vaccinations, including boosters, for your age group. However, patients who have certain medical conditions and/or are taking certain medications that reduce their ability to fight infections can take advantage of a long acting monoclonal antibody injection to avoid severe illness from Covid-19. This treatment must be used prior to exposure or diagnosis of COVID.

The FDA has issued an EUA for Evusheld (tixagevimab plus cilgavimab) as a medicine used in adults and children ages 12 years and older who are moderately to severely immunocompromised. Evusheld consists of 2 monoclonal antibodies provided together to help prevent severe illness from COVID. A healthcare provider gives Evusheld as 2 separate consecutive intramuscular (IM) injections at a doctor’s office or healthcare facility.

If you have any of the medical conditions or take medications which cause immunosuppression, you may be considered eligible for this medication. You should talk to a healthcare provider to determine if preventive treatment for COVID is right for you.

Note: Evusheld is only authorized for people ages 12 and older who weigh at least 88 pounds. You also can’t be currently infected with COVID-19 or have a known recent exposure to the virus; that is, be in your isolation or quarantine periods.

Resources about the COVID vaccine

We are here to help you.

If you have questions or need help, operators are available to assist you.

Call 855-MD-GoVAX (855-634-6829)

Available resources will evolve as the Maryland vaccination effort moves forward.
Please check our resources page regularly for information and updates.